Breaking News
Get 40% Off 0
👀 Reveal Warren Buffett's stock picks that are beating the S&P 500 by +174.3% Get 40% Off
Close

Alexion Pharmaceuticals Inc (ALXN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Alexion's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Alexion historical data, for real-time data please try another search
182.50 0.00    0.00%
20/07 - Closed. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 180.13 - 182.67
Type:  Equity
Market:  United States
Alexion 182.50 0.00 0.00%

NASDAQ:ALXN Financials

 
See below for an overview of the Alexion financial reports. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track the NASDAQ:ALXN financials over time.

For the three months ended 31 March 2021, AlexionPharmaceuticals, Inc. revenues increased 13% to $1.64B. Netincome increased 14% to $636M. Revenues reflect ULTOMIRISsegment increase of 56% to $346.9M, Strensiq segmentincrease of 15% to $197.5M. Net income benefited fromAcquisition-related costs decrease of 65% to $13.2M(expense), Amortization of purchased intangible assdecrease of 28% to $53.2M (expense).

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ALXN Income Statement

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Total Revenue 1636.5 1591.8 1588.7 1444.6
Gross Profit 1511.1 1439.6 1444 1299.7
Operating Income 636.2 622.1 684.9 -1370.2
Net Income 636 535.8 578.1 -1068.1

ALXN Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Total Assets 18650.2 18103 17548.4 16703.2
Total Liabilities 6233.4 6451.8 6473.5 6212.4
Total Equity 12416.8 11651.2 11074.9 10490.8

ALXN Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  44.71%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Period Length: 3 Months 12 Months 9 Months 6 Months
Cash From Operating Activities 637.6 3002.9 2162.4 1339.6
Cash From Investing Activities -133.9 -2099.5 -2018.9 -751.5
Cash From Financing Activities -18.7 -611.9 -538.1 -430.7
Net Change in Cash 471.9 311 -395.1 149.3
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ALXN Comments

Write your thoughts about Alexion Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Jun 16, 2021 14:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bullish guys thanks you
Oc Masai
Oc Masai May 24, 2021 16:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Vote bullish thanks you management services
Jonathan Ebrahim
Jonathan Ebrahim Dec 13, 2020 12:37
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is it time to buy ALXN stock noe?
Adrian Bram
Adrian Bram Dec 13, 2020 12:37
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think so but I'm not sure why its not moving altho theres a deal with AstraZeneca valuing it at 175 per share
Mohamed ElMeligy
Mohamed ElMeligy Dec 13, 2020 12:37
Saved. See Saved Items.
This comment has already been saved in your Saved Items
👍🏼
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email